EVFM
Evofem Biosciences, Inc.·Healthcare
0.01
3.448%(+0.00)
Market ClosedLast Updated: — ET
52W L: $0.0152W H: $0.02
EVFM NEWS
defenseworld.net
Mar 26
Head-To-Head Survey: Evofem Biosciences (NASDAQ:EVFM) and Ayala Pharmaceuticals (NASDAQ:ADXS)
Valuation and Earnings This table compares Ayala Pharmaceuticals and Evofem Biosciences"s gross revenue, earnings per share (EPS) and valuation. Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Ayala Pharmaceuticals $3.24 million 11.05 -$48.07 million ($5.02) -0.12 Evofem Biosciences $11.39 million 0.10 $52.98 million ($0.03) -0.28 Evofem Biosciences has higher revenue and earnings
businesswire.com
Mar 11
Evofem Reports Fifth Consecutive Year of Net Sales Growth
SAN DIEGO--(BUSINESS WIRE)---- $EVFM #BV--Women's health pioneer Evofem reported its fifth consecutive year of top line growth, with 2025 net product sales of more than $20 million.
businesswire.com
Jan 23
Evofem CEO Saundra Pelletier Calls for a “Ground-Up Reset” of Women's Health at Fierce JPM Week 2026
SAN DIEGO--(BUSINESS WIRE)---- $EVFM #Fierce--Evofem CEO's fiery keynote address at Fierce JPM Week 2026 calls for “Ground-Up Reset” of Women's Health. Replay now live at fiercejpmweek.com.
businesswire.com
Jan 21
Evofem Expands “Say Vagina” Campaign With Launch of Say Vagina Store
SAN DIEGO--(BUSINESS WIRE)---- $EVFM #sayvagina--Evofem launched SayVaginaStore.com, expanding its 'Say Vagina' campaign addressing widespread censorship of female anatomical terms in the media.
